Skip to main content
Tetra Bio-Pharma Inc. logo

Tetra Bio-Pharma Inc. — Investor Relations & Filings

Ticker · TBPMQ ISIN · CA88166Y1007 LEI · 5299000CYH3P8XC2UO53 TSX Manufacturing
Open in API
Filings indexed 720 across all filing types
Latest filing 2021-02-25 Regulatory Filings
Country CA Canada
Listing TSX TBPMQ

About Tetra Bio-Pharma Inc.

https://tetrabiosciences.com/

Tetra Bio-Pharma is a biopharmaceutical company specializing in the discovery and development of cannabinoid-derived drugs and medicinal plant-based products. The company maintains an advanced pipeline encompassing biopharmaceuticals, natural health, and veterinary products. Clinical programs are focused on therapeutic areas such as inflammation, pain management (including alternatives to opioids), and ophthalmology. Tetra emphasizes rigorous clinical trials and scientific evidence, utilizing novel approaches, unique mechanisms of action, and high-quality delivery methods to address unmet patient needs.

Recent filings

Filing Released Lang Actions
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F1 Certification of Annual Filings by the CFO of Tetra Bio-Pharma Inc. It certifies the review and fair presentation of the annual filings including the AIF, annual financial statements, and annual MD&A for the fiscal year ended November 30, 2020. The document is primarily an officer certification letter attesting to the accuracy and completeness of the annual filings and the effectiveness of disclosure controls and internal controls over financial reporting. It does not contain the actual financial statements or substantive financial data itself, but rather certifies those filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual annual report (10-K) or management reports (MDA). The document length is 4600 characters, which is relatively short and consistent with a certification letter rather than a full report. Therefore, the correct classification is Regulatory Filings (RNS) with high confidence.
2021-02-25 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109F1 Certification of Annual Filings by the CEO of Tetra Bio-Pharma Inc. It certifies the review and fair presentation of the annual filings for the financial year ended November 30, 2020. The content is primarily an officer certification regarding the accuracy and completeness of the annual filings, disclosure controls, and internal control over financial reporting. It does not contain actual financial statements or substantive financial data but is a formal attestation related to the annual report. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) itself.
2021-02-25 English
Annual information form - English.pdf
Annual Report Classification · 95% confidence The document is titled 'Annual Information Form For the year ended November 30, 2020' and dated February 24, 2021. It contains detailed sections typical of an Annual Information Form (AIF), including corporate structure, business development, risk factors, capital structure, directors and management, audit and risk committee information, legal proceedings, and other comprehensive disclosures. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The AIF is a regulatory filing commonly used in Canadian securities regulation to provide detailed information about a company, often filed annually alongside or as a supplement to the annual report. Given the detailed nature and the title, this document fits best under the category of Annual Report (10-K), which covers full yearly company activity and financial performance. Although the document is an AIF rather than a 10-K specifically, the closest and most appropriate classification in the provided taxonomy is 10-K, as it is a comprehensive annual report equivalent. FY 2020
2021-02-25 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'UNANIMOUS SHAREHOLDERS’ AGREEMENT' and is a detailed legal agreement between shareholders of a corporation. It includes articles on definitions, terms, corporate governance, financing, share transfer restrictions, and other shareholder rights and obligations. There is no indication that this is a financial report, earnings release, regulatory filing, or any other type of corporate filing related to financial performance or governance announcements. Instead, it is a contractual agreement among shareholders outlining their rights and responsibilities. Such documents are not classified under the provided categories for financial or regulatory filings but rather fall under agreements related to shareholder arrangements. Since none of the specific filing categories directly correspond to shareholder agreements, the best fit is the fallback category 'Regulatory Filings (RNS)' which covers miscellaneous filings that do not neatly fit into other categories.
2021-02-25 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the upsizing of a previously announced equity offering by Tetra Bio-Pharma Inc. It details the terms of the offering, including the number of units, pricing, use of proceeds, underwriters, and regulatory approvals. There is no financial statement or detailed financial analysis included, only an announcement of a financing event. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2021-02-24 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Warrant Indenture' and details the terms, conditions, and legal framework for the issuance and management of warrants by E3 Metals Corp. It includes articles on interpretation, issuance, exercise, adjustments, rights, enforcement, meetings, and the role of the warrant agent. The content is a legal contract governing the warrants, not a financial report, announcement, or regulatory filing. It does not contain financial statements, management discussion, voting results, or other report types defined in the filing categories. Therefore, it best fits under Regulatory Filings (RNS) as a miscellaneous legal document that does not fit other specific categories.
2021-02-24 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.